Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

iShares U.S. Pharmaceuticals ETF (IHE)

155.80
Delayed Data
As of Sep 22
 -0.34 / -0.22%
Today’s Change
129.20
Today|||52-Week Range
160.92
+10.17%
Year-to-Date

Investment Objective

The investment seeks to track the investment results of Dow Jones U.S. Select Pharmaceuticals Index. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins. The fund is non-diversified.

No recent news for iShares U.S. Pharmaceuticals ETF.

Performance

1 month+4.35% 3 years+4.83%
3 months-1.87% 5 years+12.96%
1 year+1.22% Since inception+12.06%
Data through 09/23/2017

Quote Details

Previous close$156.14
Open day’s range155.22 – 155.84
Net asset value (NAV)155.77 (09/22/2017)
Daily volume5,583
Average volume (3 months)20,507
Data as of 3:57pm ET, 09/22/2017

Peer Comparisonvs. Health ETFs

 IHECategory
Performance 5-yr return+12.96%+17.39%
Expense Gross exp ratio0.44%1.33%
Risk 5 year sharpe ratio0.911.13
Net assets$644.5M$3.1B
Average market cap$16.7B$32.0B
Average P/E26.722.7
Dividend / Share--0.28%

Competitors

XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF

Holdings

Top 5 Sectors
Portfolio weighting
Healthcare 98.99%
Consumer goods 1.01%
Business service 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
JNJ Johnson & Johnson9.91%
PFE Pfizer8.32%
MRK Merck7.59%
BMY Bristol-Myers Squibb6.79%
LLY Eli Lilly and Co5.80%
AGN Allergan5.68%
ZTS Zoetis Inc4.05%
PRGO Perrigo Company PLC3.05%
MYL Mylan NV2.69%
JAZZ Jazz Pharmaceuticals PLC2.59%